Hennion & Walsh Asset Management, Inc.
Position in UTHR — UNITED THERAPEUTICS Corp
CIK 1861642
Parsippany, NJ
Position in UTHR
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$3,673,511
+$626,250 QoQ
Shares Held
6,195
-0.9% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in UTHR Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Hennion & Walsh Asset Management, Inc. holds $39,326,268 across 12 Drug Manufacturers - Specialty & Generic names. UTHR ranks #4 (9.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
|
337,044 | $10,151,765 | |
| 2 | INDV |
Indivior Pharmaceuticals, Inc.
|
330,691 | $10,079,461 | |
| 3 | SUPN |
Supernus Pharmaceuticals, Inc.
|
88,454 | $4,572,187 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
This page
|
6,195 | $3,673,511 | |
| 5 | PCRX |
Pacira BioSciences, Inc.
|
155,396 | $3,511,949 | |
| 6 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
67,341 | $3,242,469 | |
| 7 | BCRX |
Biocryst Pharmaceuticals Inc
|
113,881 | $1,084,147 | |
| 8 | AKBA |
Akebia Therapeutics, Inc.
|
633,253 | $880,221 |
All Filings in UTHR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,673,511 | 6,195 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $3,047,261 | 6,254 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $2,672,044 | 6,374 | Shares | Sole | 2025-10-22 | |
| 2025-06-30 | $1,562,896 | 5,439 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $1,324,636 | 4,297 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $821,058 | 2,327 | Shares | Sole | 2025-01-15 | |
| 2024-09-30 | $1,535,888 | 4,286 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $1,039,428 | 3,263 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $756,008 | 3,291 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $632,843 | 2,878 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $659,314 | 2,919 | Shares | Sole | 2023-10-27 | |
| 2023-06-30 | $598,011 | 2,709 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $594,389 | 2,654 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $1,429,938 | 5,142 | Shares | Sole | 2023-01-12 | |
| 2022-09-30 | $4,073,697 | 19,456 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,882,696 | 20,721 | Shares | Sole | 2022-07-19 | |
| 2022-03-31 | $6,834,265 | 38,093 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $8,548,124 | 39,560 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $7,839,112 | 42,470 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,726,829 | 43,068 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $6,368,303 | 38,072 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||